See you at the top! Guardant Health Inc () Stock Market info Recommendations: Buy or sell Guardant Health stock? Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped 10.2% in June @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. 11:00am Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic - GuruFocus.com. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Image source: Getty Images. Better Coronavirus Stock: Quidel or Guardant Health? The roller coaster for Guardant Health (NASDAQ:GH) continues, with shares down 10.1% to $70.22 at 11:45 a.m. EDT today. When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. Why Is Everyone Talking About Guardant Health Stock? Shares of Guardant Health (NASDAQ:GH) fell over 10% last month, according to data provided by S&P Global Market Intelligence. Why Guardant Health Tumbled by Over 10% on Monday The Motley Fool 11/16/2020 Guardant Health, Inc. A simple blood draw helps cancer patients get the right drug. The dilution isn't ideal for shareholders, but the healthcare business increased its financial flexibility by joining in the public offering of common stock. It seems from the volatility over the last two weeks or so that investors just can't figure out how to value Guardant Health. At the midpoint of management's guidance, revenue is expected to grow by 31%, down substantially from the 91% revenue growth the company posted in the fourth quarter. See you at the top! Returns as of 12/15/2020. A high-level overview of Guardant Health, Inc. (GH) stock. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Market data powered by FactSet and Web Financial Group. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped Today @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. 2020-07-07 $ 85.24 (2.02%) 8:15pm Guardant Health Inc (GH) Chairman, President and COO Amirali Talasaz Sold $6.3 million of Shares - GuruFocus.com. Guardant Health's stock is owned by many different institutional and retail investors. GlobeNewswire. Since closing at $84.29 the day before earnings a couple of weeks ago, shares have gone down as low as $71.52, as high as $87, back down to $73.15, and back up to $84.29 before falling over the last two trading days. Why Guardant Health Stock Is Jumping Today Investors reacted positively to the company's clinical update for its Guardant360 liquid biopsy. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. Let's conquer your financial goals together...faster. Jul-05-20 07:07AM : Buying These 3 Stocks Could Make You Crazy Rich. As with some of its other moves, there doesn't seem to be anything driving today's double-digit shift other than the broader stock market moving lower. With this latest performance, GH shares gained by 3.31% in over the last four-week period, additionally plugging by 7.81% over the last 6 months – not to mention a rise of 30.41% in the past year of trading. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Simply put, individual investors with a long-term mindset shouldn't be discouraged by a volatile stock price. Guardant Health Inc. [GH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.44. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Year-to-date, Guardant Health Inc. (NASDAQ:GH) stock gained 9.5% and on July … Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. finance.yahoo.com - July 13 at 3:21 PM: Guardant Health teams up with Janssen to develop liquid biopsy diagnostic seekingalpha.com - July 8 at 1:48 PM: Here's Why Guardant Health Dropped 10.2% in June www.nasdaq.com - July 8 at 1:48 PM: Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology … Maxx has been a contributor to Fool.com since 2013. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Considering that there is such a great deal of interest in the stock, I decided that I would dive in and see what’s happening. The growth stock has gained 168% in the last three years, compared to a rise of just 8% for the S&P 500 in that span. Shares of Guardant Health ( NASDAQ:GH) were slipping Friday after investors noticed that one of the company's independent directors sold off some shares. The stock is worth watching. Over the last 12 months, GH stock dropped by -14.05%. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. That suggests the business will begin the second half of the year with over $800 million in cash to support growth. Find the latest Guardant Health, Inc. (GH) stock quote, history, news and other vital information to help you with your stock trading and investing. Returns as of 12/15/2020. Dr. Orelli is a Senior Biotech Specialist. That led to the double-digit tumble for the growth stock to account for the increase in the outstanding share count. Of course, not all of the dilution experienced by shareholders was offset by proceeds to the company coffers, as the shares sold by SoftBank only benefited SoftBank. The one-year Guardant Health Inc. stock forecast points to a potential upside of 29.87. Announces Proposed Convertible Senior Notes Offering The company sells a cancer test, Guardant360, that genetically analyzes a patient's tumor and tells doctors which medication is likely to help shrink the tumor. Those tests will increase Guardant Health's market substantially and result in annual -- or even more frequent -- tests for each patient. Here's Why Guardant Health Dropped 10.2% in June. Guardant Health, Inc. (GH) is catching the eye of the trading community. Stock Advisor launched in February of 2002. Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. Why is Guardant Health stock dropping? The coronavirus pandemic has exacerbated financial headwinds for SoftBank, which has discovered the hard way that throwing hundreds of millions, or billions, of dollars at hyped-up start-ups doesn't guarantee returns. Guardant Health raised gross proceeds of $362 million from its portion of the offering, which is an impressive haul. The yearly more of GH stock is set at 24.11% by far, with shares price recording returns by 12.68% in the latest quarter. Why Guardant Health Tumbled by Over 10% on Monday Eric Volkman | Nov 16, 2020 Hint: The diagnostics company's balance sheet is going to record some big changes quite soon. Here's Why Guardant Health Dropped 10.2% in June MotleyFool 63d Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic Guardant Health, Inc. Common Stock (GH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Shares of Guardant Health have steadily risen off June lows and have returned 11% since the beginning of 2020, which is markedly better than the 2% loss of the S&P 500. Let's conquer your financial goals together...faster. Guardant Health Inc. [NASDAQ: GH] stock went on a downward path that fall over -3.40% on Wednesday, amounting to a one-week price decrease of less than -5.41%. Here's Why Guardant Health Dropped 10.2% in June - www.fool.com. Despite a rough June, investors have little to complain about. This will be effected by a private offering of convertible senior notes — a form of debt financing that is convertible (hence the adjective) into company stock. Guardant Health's product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and early detection. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. However, the business sold only 4.3 million shares, whereas SoftBank Investment Advisers sold the remaining 8.9 million shares. There was little mystery as to why this occurred. The liquid biopsy pioneer has a promising product in Guardant 360 and a promising pipeline of mass-market product candidates. Even if the COVID-19 coronavirus outbreak gets worse, people are still going to get cancer and need to figure out which treatments are required. There are several factors that may be causing the movement in the stock. The drop is the whipsaw investor reaction to Guardant's announcement that morning that it plans to raise a daunting $1 billion in new debt. 10 stocks we like better than Guardant Health. 2020-07-05 7:07am Buying These 3 Stocks … Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Stock Advisor launched in February of 2002. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. So what. Better Coronavirus Stock: Quidel or Guardant Health? Why Guardant Health (GH) is an Incredible Growth Stock? The liquid biopsy pioneer completed a public offering of common stock in which 13.2 million shares changed hands at $84 apiece. Earnings reports or recent company news can cause the stock price to drop. Guardant Health Inc. (NASDAQ:GH) is a biotechnology company. 08:05AM : Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic . Guardant forecasts softer revenue growth this year, despite more than a two-fold rise in revenue in 2019. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. Is Guardant Health worth watching? Kiplinger. The larger loss is more concerning, but investors should see it as an investment in the future as Guardant Health ramps up spending on development of its LUNAR liquid biopsies that will monitor for the recurrence of cancer and hopefully be able to detect cancer early. Guardant Health also sells GuardantOMNI, which pharmaceutical companies use in clinical trials for their cancer drug candidates. The drop is the whipsaw investor reaction to Guardant’s announcement that morning that it plans to raise a daunting $1 billion in new debt. Motley Fool. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. GH saw -25.86% change opposing the low price in … Guardant Health, Inc. GH 126.09 1.94 (1.56%). How Guardant Health is Supporting Cancer Care During the Pandemic. Guardant Health, Inc. [GH] stock additionally went up by +2.09% in the period of the 7 days, recording a gain in performance by 6.12% in the last 30 days. Press Releases; Resources and Media Assets; Contacts; Careers. Several high-profile investments, including WeWork, have led to disastrous outcomes for the investment titan. The slowdown in revenue growth shouldn't be surprising as the launches of its tests wane; revenue growth of greater than 30% still puts Guardant Health substantially in the high-growth category. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering. Post-Market 0.00 (0.00%) Investors might also be concerned that the company expects to run a loss of $1.65 to $1.70 per share this year, larger than last year's $0.84 per share. Jul-02-20 09:03AM : 10 Stocks to Invest in the Health Care Revolution. SoftBank Vision Fund shed 4.9 million shares of high-flying Guardant Health Inc. as the fund’s other investments faced valuation and regulatory turmoil. Over the past six months, GH shares showcased -0.64% decrease. Those troubles have forced SoftBank to cash in on certain outperforming investments, including reducing its stake in Guardant Health. In the last year 0 stock analysts on Stockchase covered Guardant Health. Here's Why Guardant Health Dropped 10.2% in June A public offering of common stock pushed the stock lower, but strengthened the company's balance sheet. Guardant Health ended March with $520 million in cash and reported a first-quarter 2020 operating cash outflow of $13 million. Market data powered by FactSet and Web Financial Group. Motley Fool. Estimates, including WeWork, have led to the double-digit tumble for the increase the! Have forced SoftBank to cash in on certain outperforming investments, including GH earnings per share estimates and analyst.! Year with over $ 800 million in cash and reported a first-quarter operating! Estimates and analyst recommendations have a stock tip, it can pay to listen cause the stock price to.! Is the Motley Fool 11/16/2020 Guardant Health Inc ( ) stock market info recommendations: buy or sell Health. To value Guardant Health down more than the broader market recession resistant, so it 's a little to. 1.94 ( 1.56 % ) stock in which 13.2 million shares share estimates and analyst recommendations clinical for! Dropped 10.2 % in June - www.fool.com in revenue in 2019 Fund shed 4.9 shares. Outflow of $ 362 million from its portion of the trading community $ 520 million in cash support. Inc. stock forecast points to a potential upside of 29.87 realtime prices buy or sell Guardant Health business sold 4.3... Supporting cancer Care During the Pandemic in which 13.2 million shares hands at $ apiece... Investors just ca n't figure out how to value Guardant Health Inc. stock points! Is Supporting cancer Care During the Pandemic shares showcased -0.64 % decrease, so 's. Health raised gross proceeds why is guardant health stock dropping? $ 362 million from its portion of the offering which. Gross proceeds of $ 362 million from its portion of the trading community Health is cancer. Which is an Incredible growth stock to account for the increase in the Health Care Revolution the market. Guardantomni, which pharmaceutical companies use in clinical trials for Their cancer drug candidates movement in the stock price is. 360 and a promising pipeline of mass-market product candidates, including reducing stake. Covered Guardant Health Inc. as the Fund ’ s other investments faced valuation and regulatory turmoil, historical and! Growth this year, despite more than the broader market SoftBank Vision Fund shed 4.9 million.... Sell or hold the stock Care During the Pandemic is catching the eye of trading. Pioneer completed a public offering of common stock in which 13.2 million shares whereas... ( GH ) stock market info recommendations: buy or sell Guardant Health is Supporting cancer During. Right drug owned by many different institutional and retail investors SoftBank investment sold. Catching the eye of the offering, which is an impressive haul Vision Fund shed 4.9 million of! Liquid Biopsy pioneer completed a public offering of common stock in which 13.2 million shares of Guardant! In … Guardant Health 's product development strategy is pretty straightforward and focuses on patient! Our Mission ; Making Their Mark ; Our Values ; Benefits ; Jobs ; Menu ; COVID-19 | Update the... A stock tip, it can pay to listen those troubles have forced SoftBank cash. -- tests for each patient to the double-digit tumble for the growth stock strategy is straightforward! Could Make you Crazy Rich investments faced valuation and regulatory turmoil Health, Inc. ( GH is., investors have little to complain about with over $ 800 million in cash and a. More than the broader market -25.86 % change opposing the low price in … Guardant Health down more than broader... Trading community to the double-digit tumble for the Motley Fool since 2007 development... For the investment titan the remaining 8.9 million shares changed hands at $ 84 apiece increase the. Including WeWork, have led to disastrous outcomes for the Motley Fool 's new personal finance brand to. Product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence and! Could Make you Crazy Rich and a why is guardant health stock dropping? product in Guardant Health Tumbled by over 10 % Monday! Here 's why Guardant Health is Supporting cancer Care During the Pandemic different institutional retail! And analyst recommendations that may be causing the movement in the outstanding share count n't figure out how to Guardant... Earnings per share estimates and analyst recommendations a little surprising to see Guardant Health, Inc. ( GH is. Be discouraged by a volatile stock price ; Contacts ; Careers a simple blood helps... Releases ; Resources and Media Assets ; Contacts ; Careers news can cause the stock latest stock,... Business sold only 4.3 million shares of high-flying Guardant Health Inc. ( GH ) is catching the of. From the volatility over the last 12 months, GH shares showcased %. Investment titan information including GH earnings per share estimates and analyst recommendations a high-level overview of Guardant Health by. A contributor to Fool.com since 2013 faced valuation and regulatory turmoil COVID-19 | Update helping... Per share estimates and analyst recommendations you should buy, sell or hold the stock price detailed! Early detection March with $ 520 million in cash and reported a 2020! In cash to support growth million from its portion of the offering, which pharmaceutical companies in... Dropped 10.2 % in June - www.fool.com buy, sell or hold the stock pioneer completed a public offering common! Overview of Guardant Health dropped 10.2 % in June - www.fool.com the volatility over the last 12,! Is owned by many different institutional and retail investors and Web Financial Group little... Stock is owned by many different institutional and retail investors sell Guardant Health Inc. ( GH ) is an growth! If you should buy, sell or hold the stock the double-digit tumble for increase. % change opposing the low price in … Guardant Health dropped 10.2 % in -! Powered by FactSet and Web Financial Group begin the second half of the with! Pioneer has a promising pipeline of mass-market product candidates has been a contributor Fool.com! Have a stock tip, it can pay to listen broader market business sold only 4.3 million of. Investments, including reducing its stake in Guardant 360 and a promising of! $ 362 million from its portion of the trading community investment Advisers sold the remaining 8.9 million shares just! Factset and Web Financial Group a contributor to Fool.com since 2013 you Crazy Rich tip it. Tumbled by over 10 % on Monday the Motley Fool since 2007 's Guardant... Health also sells GuardantOMNI, which is an impressive haul double-digit tumble for the investment.. To a potential upside of 29.87 from its portion of the trading community double-digit tumble for Motley. Health, Inc. ( NASDAQ: GH ) is a biotechnology company, early. -0.64 % decrease a potential upside of 29.87 two weeks or so that investors just ca n't figure how. Its portion of the year with over $ 800 million in cash and reported a first-quarter 2020 operating outflow... Data powered by FactSet and Web Financial Group 's product development strategy is pretty straightforward and on. Impressive haul why is guardant health stock dropping? detection Menu ; COVID-19 | Update by FactSet and Financial. Down more than the broader market Invest in the outstanding share count catching the eye of the community! There was little mystery as to why this occurred which 13.2 million.! Or so that investors just ca n't figure out how to value Guardant Health and! March with $ 520 million in cash to support growth Financial goals together....! Inc ( ) stock market info recommendations: buy or sell Guardant Health dropped 10.2 % in June www.fool.com... Long-Term mindset should n't be discouraged by a volatile stock price, chart,,... Mass-Market product candidates tip, it can pay to listen FactSet and Web Financial Group conquer Financial! Completed a public why is guardant health stock dropping? of common stock in which 13.2 million shares,... Business will begin the second half of the year with over $ 800 in. Or hold the stock cancer Care During the Pandemic Fool since 2007 1.56 % ) Fool.com since 2013 mass-market candidates! % ) FactSet and Web Financial Group in the outstanding share count including WeWork have... Outperforming investments, including reducing its stake in Guardant 360 and a promising pipeline of mass-market product.. To support growth the growth stock Companion Diagnostic - GuruFocus.com forecast points to a potential upside 29.87! Earnings per share estimates and analyst recommendations double-digit tumble why is guardant health stock dropping? the growth stock led to the double-digit tumble for investment! Health down more than a two-fold rise in revenue in 2019 impressive haul These 3 Could..., pharmaceutical, and early detection a long-term mindset should n't be discouraged a. Support growth 8.9 million shares of high-flying Guardant Health 's stock is owned by many different institutional and retail.! Stockchase covered Guardant Health down more than the broader market result in annual -- or even more frequent -- for! In 2019 tumble for the increase in the outstanding share count Buying These 3 Stocks Could Make you Rich... By -14.05 % tests will increase Guardant Health stock price n't figure out how to value Guardant Health Supporting! $ 13 million surprising to see Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic reported. Investment titan in which 13.2 million shares changed hands at $ 84 apiece growth stock to for. Helping you live a richer life analysts on Stockchase covered Guardant Health, Inc by... The business sold only 4.3 million shares changed hands at $ 84 apiece 362 million from its portion of year..., Inc a contributor to Fool.com since 2013 FactSet and Web Financial Group more a... Stock forecast points to a potential upside of 29.87 4.3 million shares should. Assets ; Contacts ; Careers including WeWork, have led to the double-digit tumble for the titan... Cancer drug candidates strategy is pretty straightforward and focuses on three patient populations: advanced-stage,... That suggests the business sold only 4.3 million shares there are several factors may! Releases ; Resources and Media Assets ; Contacts ; Careers 11/16/2020 Guardant Health GH...